| |
| |
| Exchange: |
Over The Counter |
| Security
Type: |
Common |
| Shares
Out: |
27,480,000 |
| Market
Cap: |
39.30(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.29 - $2.38 |
|
| Level
I Sector: |
Basic Materials |
| Level
II Sector: |
Chemicals |
| Level
III Sector: |
Synthetics |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Dyadic International is a global biotechnology platform company and it utilizes a number of third-party consultants and research organizations to carry out its activities. Co. has developed a gene expression platform for producing commercial quantities of enzymes and other proteins. This technology is based on the Thermothelomyces heterothallica fungus, which Co. named C1. The C1-cell protein production platform is a versatile thermophilic filamentous fungal expression system for the development and production of biologic products including enzymes and other proteins.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
8,943 |
| Total Sell Value |
$0 |
$0 |
$0 |
$31,202 |
| Total People Sold |
0 |
0 |
0 |
1 |
| Total Sell Transactions |
0 |
0 |
0 |
2 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• • – |
2024-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
11,169 |
23,853 |
|
- |
|
| Hazelton Joseph P |
Chief Business Officer |
• • – |
2024-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
41,720 |
99,168 |
|
- |
|
| Rawson Ping Wang |
Chief Financial Officer |
• • – |
2024-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
35,366 |
120,217 |
|
- |
|
| Emalfarb Mark A |
President and CEO |
• • • |
2024-03-13 |
4 |
A |
$0.00 |
$0 |
D/D |
124,454 |
4,656,947 |
|
- |
|
| Buckland Barry |
Director |
• • – |
2024-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,174 |
27,174 |
|
- |
|
| Lucy Patrick K. |
Director |
• • – |
2024-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,174 |
27,174 |
|
- |
|
| Tarnok Michael P. |
Director |
• • – |
2024-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,174 |
216,103 |
|
- |
|
| Herbst Seth |
Director |
• • – |
2024-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,174 |
132,174 |
|
- |
|
| Bose Arindam |
Director |
• • – |
2024-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,174 |
27,174 |
|
- |
|
| Kaye Jack |
Director |
• • – |
2024-01-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
27,174 |
33,581 |
|
- |
|
| Emalfarb Mark A |
President and CEO |
• • • |
2023-01-03 |
4 |
A |
$1.38 |
$191,100 |
D/D |
138,478 |
4,532,493 |
|
- |
|
| Hazelton Joseph P |
Chief Business Officer |
• • – |
2023-01-03 |
4 |
A |
$1.38 |
$79,278 |
D/D |
57,448 |
57,448 |
|
- |
|
| Rawson Ping Wang |
Chief Financial Officer |
• • – |
2023-01-03 |
4 |
A |
$1.38 |
$54,304 |
D/D |
39,351 |
84,851 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• • – |
2023-01-03 |
4 |
A |
$1.38 |
$17,504 |
D/D |
12,684 |
12,684 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• • – |
2022-07-08 |
4 |
AS |
$3.41 |
$3,713 |
D/D |
(1,089) |
0 |
|
-46% |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• • – |
2022-07-08 |
4 |
OE |
$1.57 |
$1,710 |
D/D |
1,089 |
1,089 |
|
- |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• • – |
2022-07-07 |
4 |
AS |
$3.50 |
$27,489 |
D/D |
(7,854) |
0 |
|
-46% |
|
| Tchelet Ronen |
VP of Research and Bus. Dvlpmt |
• • – |
2022-07-07 |
4 |
OE |
$1.57 |
$12,331 |
D/D |
7,854 |
7,854 |
|
- |
|
| Herbst Seth |
Director |
• • – |
2022-01-28 |
4 |
OE |
$1.21 |
$30,250 |
D/D |
25,000 |
25,000 |
|
- |
|
| Emalfarb Mark A |
President and CEO |
• • • |
2021-12-23 |
4 |
OE |
$1.63 |
$244,500 |
I/I |
150,000 |
4,394,015 |
|
- |
|
| Emalfarb Mark A |
President and CEO |
• • • |
2021-12-23 |
4 |
S |
$4.10 |
$117,945 |
I/I |
(28,767) |
4,244,015 |
|
46% |
|
| Emalfarb Mark A |
President and CEO |
• • • |
2021-12-22 |
4 |
S |
$4.12 |
$146,874 |
I/I |
(35,649) |
4,272,782 |
|
46% |
|
| Emalfarb Mark A |
President and CEO |
• • • |
2021-12-21 |
4 |
S |
$4.33 |
$114,684 |
I/I |
(26,486) |
4,308,431 |
|
50% |
|
| Francisco Trust Under Agreement Dated February 28, |
10% Owner |
– – • |
2021-08-11 |
4 |
S |
$770,984.00 |
$2,147,483,647 |
D/D |
(150,000) |
3,548,528 |
|
17% |
|
| Francisco Trust Under Agreement Dated February 28, |
10% Owner |
– – • |
2021-07-27 |
4 |
S |
$103,965.00 |
$2,147,483,647 |
D/D |
(25,000) |
3,698,528 |
|
13% |
|
101 Records found
|
|
Page 1 of 5 |
|
|
0.02 (1.42%) 
